# Presentation: 915446

## GonorrheaSexually Transmitted Disease Surveillance 2005

- Division of STD Prevention

## Gonorrhea — Rates: United States, 1941–2005 and the Healthy People 2010 target

- Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population.

## Gonorrhea — Rates: Total and by sex: United States, 1986–2005 and the Healthy People 2010 target

- Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000
- population.

## Gonorrhea — Rates by region: United States, 1996–2005 and theHealthy People 2010 target

- Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population.

## Gonorrhea — Rates by state: United States and outlying areas, 2005

- Note: The total rate of gonorrhea for the United States and outlying areas (Guam, Puerto Rico and Virgin Islands) was 114.2 per 100,000 population. The Healthy People 2010 target is 19.0 cases per 100,000 population.

## Gonorrhea — Rates by county: United States, 2005

- Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population.

## Gonorrhea — Cases by reporting source and sex: United States, 1996–2005

## Gonorrhea — Rates by race/ethnicity: United States, 1996–2005

## Gonorrhea — Age- and sex-specific rates: United States, 2005

## Gonorrhea — Age-specific rates among women 15 to 44 years of age:United States, 1996–2005

## Gonorrhea — Age-specific rates among men 15 to 44 years of age:United States, 1996–2005

## Gonorrhea — Positivity among 15- to 24-year-old women tested in family planning clinics by state: United States and outlying areas, 2005

- *States/areas not meeting minimum inclusion criteria.
- Note: Includes states and outlying areas that reported gonorrhea positivity data on at least 500 women aged 15-24 years screened during 2005.
- SOURCE: Regional Infertility Prevention Projects; Office of Population Affairs; Local and State STD Control Programs; Centers for
- Disease Control and Prevention

## Gonococcal Isolate Surveillance Project (GISP) — Location of participating clinics and regional laboratories: United States, 2005

## Gonococcal Isolate Surveillance Project (GISP) — Penicillin and tetracycline resistance among GISP isolates, 2005

- Note: PPNG=penicillinase-producing *N. gonorrhoeae*; TRNG=plasmid-mediated tetracycline-resistant *N. gonorrhoeae*; PPNG-TRNG=plasmid-mediated penicillin- and tetracycline-resistant *N. gonorrhoeae*; PenR=chromosomally mediated penicillin-resistant *N. gonorrhoeae*; TetR=chromosomally mediated tetracycline-resistant *N. gonorrhoeae*; CMRNG=chromosomally mediated penicillin- and tetracycline-resistant *N. gonorrhoeae*.

## Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance or intermediate resistance to ciprofloxacin, 1990–2005

- Note: Resistant isolates have ciprofloxacin MICs ≥ 1 μg/ml. Isolates with intermediate resistance have ciprofloxacin MICs of 0.125 - 0.5 μg/ml. Susceptibility to ciprofloxacin was first measured in GISP in 1990.

## Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance to ciprofloxacin by sexual behavior, 2001–2005